Skip to main content
Clinical Trials/KCT0005963
KCT0005963
Not yet recruiting
未知

Development of pharmacokinetic model for the target-concentration controlled infusion of cefazolin used as a prophylactic antibiotic in surgical patients

Asan Medical Center0 sites40 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the digestive system
Sponsor
Asan Medical Center
Enrollment
40
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • ? Patients over 20 to 80 years old
  • ? Patients scheduled to undergo stomach or breast surgery at Asan Medical Center E rosette
  • ? Patients with the physical status of the American Society of Anesthesiologists, Class 1\-3
  • ? Patients who weigh 40 kg or more
  • ? Patients scheduled to receive cefazolin as a prophylactic antibiotic
  • ? Patients who have agreed in writing to voluntarily participate in this clinical study

Exclusion Criteria

  • ? Pregnant or breastfeeding women
  • ? Patients with a history of hypersensitivity to cefazolin
  • ? Patients with a history of cefazolin given within 3 days of the scheduled operation time
  • ? Patients with hemoglobin \<8 g/dl
  • ? Estimated glomerular filtration rate measured before surgery \<60 ml/min
  • ? Patients who received other clinical trial drugs within 7 days of the surgery
  • ? Patients deemed inappropriate by investigators

Outcomes

Primary Outcomes

Not specified

Similar Trials